New White Paper: Understanding and Correctly Interpreting Gene Expression Diagnostics
How does gene expression diagnostics work, and what do the results actually tell us? Gene expression-based diagnostics open up new…
9. September 2026
Dermagnostix Selected for the MedTech Innovator 2026 Accelerator Cohort
Dermagnostix has been selected for the prestigious MedTech Innovator (MTI) 2026 Accelerator Cohort, placing the company among the top 4%…
12. June 2026
Dermagnostix launches PE-TargetDisk for fully automated molecular testing in doctor’s offices
Dermagnostix GmbH is launching the PE-TargetDisk (RUO), an innovative solution for dermatology practices. The disk enables rapid molecular measurements at…
16. March 2026
Euroimmun und Dermagnostix schließen strategische Partnerschaft
Das MedTech-Unternehmen Dermagnostix, Spezialist für vollautomatisierte Plug-and-Play Molekulardiagnostik in der Dermatologie, wird im Bereich der molekularen Diagnostik von Hauterkrankungen künftig mit Euroimmun, weltweit führender Anbieter…
18. December 2025
Dermagnostix launches new TargetDisk product line – featuring the first product, Erysk-TargetDisk
Dermagnostix announces the launch of the TargetDisk product line, expanding its portfolio with innovative molecular research tools designed for dermatological…
3. November 2025
Dermagnostix at the 37th European Congress of Pathology 2025 in Vienna
This week, Vienna became the meeting point for pathologists from all over the world at the 37th European Congress of…
26. September 2025
Dermagnostix announces distribution partnership with Axon Lab AG
Freiburg/Baden-Dättwil (CH), 1 September 2025 – Dermagnostix, specialized in the development of molecular diagnostic tests for dermatological issues, starts its distribution…
26. September 2025
JuDerm podcast „Wo ich schon mal da bin“ featuring Dermagnostix CEO Prof. Dr. Natalie Garzorz-Stark
Our CEO had the honor of being the special guest on the JuDerm podcast. In episode 13, they discussed the…
19. August 2025
Dermagnostix announces acquisition and continuation of the fluorescence detector technology of Dialunox as of July 1st 2025
Freiburg im Breisgau, 05.05.2025 – The Dermagnostix GmbH from Freiburg, specialized on the development of molecular diagnostic tests for dermatology,…
5. May 2025
